Status:
COMPLETED
Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS Infants
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Prader Willi Syndrome
Eligibility:
All Genders
1-5 years
Phase:
PHASE1
PHASE2
Brief Summary
The Prader-Willi syndrome (PWS) includes severe neonatal hypotonia with impaired suckling leading to failure to thrive in the most severe cases, subsequently followed by an early onset of morbid obesi...
Detailed Description
Prader-Willi syndrome (PWS) is a rare, complex multisystem genetic disorder arising from the lack of expression of paternally inherited imprinted genes on chromosome 15q11-q13. The syndrome includes s...
Eligibility Criteria
Inclusion
- Infants with PWS genetically confirmed
- Aged less than 5 months
Exclusion
- Infants presenting hepatic insufficiency
- Infants presenting renal insufficiency
- Infants with abnormal ECG
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT02205034
Start Date
May 1 2013
End Date
July 1 2014
Last Update
February 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de réfrence Prader-Willi, Hospital of infants
Toulouse, France, 31059